Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. Company
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Delayed Quote. Delayed Swiss Exchange - 12/03 11:30:38 am
73.57 CHF   -0.31%
12/03Bryan Garnier Downgrades Novartis to Neutral from Buy
MT
12/03NOVARTIS AG : UBS reaffirms its Neutral rating
MD
12/03NOVARTIS AG : Sell rating from JP Morgan
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novartis AG
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Number of employees : 105 794 people.
Sales per Business
20192020Delta
Innovative Medicines37 479.5079.4%36 618.1080.2% -2.3%
Sandoz9 670.5020.5%9 053.8719.8% -6.38%
CHF in Million
Sales per region
2020
United States15 472.1033.9%
Europe10 282.5022.5%
Asia/Africa/Australasia4 544.7710%
Germany4 240.669.3%
Canada and Latin America3 042.056.7%
Japan2 631.875.8%
China2 415.055.3%
France2 292.105%
Switzerland750.891.6%
CHF in Million
Managers
Name Title Age Since
Vasant Narasimhan Chief Executive Officer 44 2018
Harry Werner Kirsch Chief Financial Officer 55 2013
John Tsai Chief Medical Officer 53 2018
Klaus Moosmayer Chief Ethics Risk & Compliance Officer 52 2018
Andreas von Planta, Dr. Independent Non-Executive Director 66 2006
Ann Marie Fudge Independent Non-Executive Director 70 2008
Enrico Cipro Vanni, Dr. Vice Chairman 69 2011
Charles L. Sawyers, Dr. Independent Non-Executive Director 61 2013
William Thomas Winters Independent Non-Executive Director 60 2013
J÷rg Reinhardt Independent Non-Executive Chairman 64 2013
Members of the board
Name Title Age Since
J÷rg Reinhardt Independent Non-Executive Chairman 64 2013
Andreas von Planta, Dr. Independent Non-Executive Director 66 2006
Ann Marie Fudge Independent Non-Executive Director 70 2008
Enrico Cipro Vanni, Dr. Vice Chairman 69 2011
Charles L. Sawyers, Dr. Independent Non-Executive Director 61 2013
William Thomas Winters Independent Non-Executive Director 60 2013
Nancy C. Andrews, Dr. Independent Non-Executive Director 61 2015
Mary Elizabeth Doherty Independent Non-Executive Director 63 2016
Ton BŘchner Independent Non-Executive Director 55 2016
Frans Van Houten Independent Non-Executive Director 61 2017
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,467,060,920 2,114,397,903 85.7% 229,969,401 9.3% 85.7%
Shareholders
NameEquities%
Novartis AG 95,088,390 3.91%
Sandoz Family Foundation 89,135,960 3.66%
The Vanguard Group, Inc. 59,498,155 2.44%
UBS Asset Management Switzerland AG 56,764,402 2.33%
Norges Bank Investment Management 56,446,398 2.32%
Novartis Foundation For Employee Participation 49,094,512 2.02%
Wellington Management Co. LLP 44,081,927 1.81%
Credit Suisse Asset Management (Schweiz) AG 32,426,039 1.33%
ZŘrcher Kantonalbank (Investment Management) 23,045,100 0.95%
Dodge & Cox 20,985,270 0.86%
Holdings
NameEquities%Valuation
NOVARTIS INDIA LIMITED (500672) 17,450,680 70.7% 173,000,806 USD
SOMALOGIC, INC. (SLGC) 10,422,469 5.75% 132,678,030 USD
PLIANT THERAPEUTICS, INC. (PLRX) 2,153,526 5.99% 34,305,669 USD
MOLECULAR PARTNERS AG (MOLN) 1,739,130 5.39% 32,736,566 USD
XOMA CORPORATION (XOMA) 539,131 4.77% 13,478,275 USD
GENSIGHT BIOLOGICS S.A. (SIGHT) 1,390,487 3.02% 11,360,543 USD
AYALA PHARMACEUTICALS, INC. (AYLA) 698,777 5.28% 7,672,571 USD
OXURION NV (OXUR) 2,177,226 5.64% 5,366,731 USD
AADI BIOSCIENCE, INC. (AADI) 42,349 0.20% 1,143,000 USD
BIOLINERX LTD. (BLRX) 4,999,995 0.70% 941,749 USD
Markets and indexes
- Domestic Standard
- SMI / FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  NOVN.S
- Datastream Code :  S:NOVS
Company contact information
Novartis AG
Lichtstrasse 35
CH-4056 Basel, Basel-Stadt

Phone : +41 61 324 11 11
Fax : +41 61 324 80 01
web site : http://www.novartis.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Novartis AG
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
NOVARTIS AG-12.05%179 058
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
PFIZER, INC.44.09%304 610
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641
ABBVIE INC.8.18%210 113
MERCK & CO., INC.-10.34%185 253
ASTRAZENECA PLC11.84%167 779
BRISTOL-MYERS SQUIBB COMPANY-9.21%125 010
SANOFI6.44%118 698
AMGEN INC.-11.95%114 028
GLAXOSMITHKLINE PLC14.35%101 616
CHUGAI PHARMACEUTICAL CO., LTD.-33.20%53 454
JIANGSU HENGRUI MEDICINE CO., LTD.-47.03%49 171
BAYER AG-8.10%49 077
DAIICHI SANKYO COMPANY, LIMITED-19.48%48 251
TAKEDA PHARMACEUTICAL COMPANY LIMITED-18.24%42 287
ASTELLAS PHARMA INC.11.79%29 201
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY36.49%22 646
CATALENT, INC.17.68%20 965